These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27438183)

  • 1. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
    Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
    Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
    Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
    Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
    Gürer R; Aydın Ş; Özkara Ç
    Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
    Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
    Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
    Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
    Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy.
    Ascoli M; Mastroianni G; Gasparini S; Striano P; Cianci V; Neri S; Bova V; Mammì A; Gambardella A; Labate A; Aguglia U; Ferlazzo E
    Expert Rev Neurother; 2021 Nov; 21(11):1265-1273. PubMed ID: 33993822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
    Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
    Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile myoclonic epilepsy].
    Syvertsen MR; Markhus R; Selmer KK; Nakken KO
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1610-3. PubMed ID: 22875125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of juvenile myoclonic epilepsy.
    Auvin S
    CNS Neurosci Ther; 2008; 14(3):227-33. PubMed ID: 18684236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.